Do you have a strategy for responding to the temperamental IPO market and making the most of alternative financing strategies?
Foley & Lardner LLP and the NanoBusiness Alliance are pleased to invite senior business executives and investors to participate in a roundtable discussion addressing how nanotechnology companies can develop financing strategies for success.
Discussion topics include:
- Financing growth and development of a nanotechnology company with long product development timelines, little or no near-term revenue, and potential applications in many industries
- Determining when the sale of your company is the most viable and what factors have made other nanotechnology companies attractive targets
- Deciding whether to go IPO, OTC, AIM, or private equity
- Exploring nontraditional financing options
- Positioning your company for the best financing options
Confirmed Palo Alto Attendees:
- Michael Knapp, Ph.D., President and Chief Executive Officer, Cambrios
- Alexei Andreev, Managing Director, Harris & Harris Group, Inc.
- Conrad Burke, President and Chief Executive Officer, Innovalight Inc.
- Amy Corinne Smith, Senior Vice President, Global Technology Group, Lehman Brothers
- Curt Creely, Partner, Foley & Lardner LLP
People
Related Insights
December 19, 2025
Health Care Law Today
Gender-Affirming Care for Minors: CMS and HHS Propose Limits on “Sex Rejection Procedures” and Expanded Enforcement Pathways
On December 18, 2025, the U.S. Department of Health and Human Services (HHS) held a press conference focused on what is defined as “sex…
December 19, 2025
Foley Viewpoints
Prohibition to Prescription: What Trump’s Marijuana Executive Order Really Means
On December 18, 2025, President Donald Trump issued an Executive Order, Increasing Medical Marijuana and Cannabidiol Research, that…
December 18, 2025
Manufacturing Industry Advisor
Foley Automotive Update
Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term…